Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene.

Saved in:
Bibliographic Details
Title: Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene.
Authors: Lazow SP; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA 02115, USA., Labuz DF; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA 02115, USA., Kycia I; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA 02115, USA., Zurakowski D; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA 02115, USA., Fauza DO; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA 02115, USA. Electronic address: dario.fauza@childrens.harvard.edu.
Source: Journal of pediatric surgery [J Pediatr Surg] 2021 Jun; Vol. 56 (6), pp. 1226-1232. Date of Electronic Publication: 2021 Feb 24.
Publication Type: Journal Article
Journal Info: Publisher: Saunders Country of Publication: United States NLM ID: 0052631 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-5037 (Electronic) Linking ISSN: 00223468 NLM ISO Abbreviation: J Pediatr Surg Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-5037
DOI:10.1016/j.jpedsurg.2021.02.036